Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test
Fenwal Inc announced that it has signed a five-year exclusive worldwide agreement with Verax Biomedical Incorporated to market, sell and distribute Verax’s unique PanGenera Detection (PGD) technology, a rapid diagnostic test used to detect bacterial contaminants in donated blood platelets.
Read More